Clinical aspects and management of levodopa-induced dyskinesia

Nicola Tambasco, Simone Simoni, Erica Marsili, Elisa Sacchini, Donatella Murasecco, Gabriela Cardaioli, Aroldo Rossi, Paolo Calabresi

Research output: Contribution to journalArticlepeer-review


In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists.

Original languageEnglish
Article number745947
JournalParkinson's Disease
Publication statusPublished - 2012

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Clinical aspects and management of levodopa-induced dyskinesia'. Together they form a unique fingerprint.

Cite this